Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 27.00
+0.15 (0.56%)
Sep 18, 2025, 1:14 PM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 779.57 million as of September 18, 2025. Its market cap has decreased by -4.38% in one year.
Market Cap
779.57M
Enterprise Value
676.01M
Revenue
230.06M
Ranking
n/a
PE Ratio
25.60
Stock Price
27.00
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 779.57M, a decrease of -59.83%. That is a compound annual growth rate of -16.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 779.57M | 22.68% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | 826.00M | -57.44% |
| Jul 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 307.10B |
| PharmaEssentia | 181.77B |
| Bora Pharmaceuticals Co., LTD. | 88.24B |
| Lumosa Therapeutics | 53.74B |
| Lotus Pharmaceutical | 48.91B |
| Oneness Biotech | 33.67B |
| Polaris Group | 28.70B |
| Center Laboratories | 27.67B |